Organon & Co | OGN - Action





Action Changement Date
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Celltrion KRW 126B 3.06B 2026-03
Cspc Pharmaceutical CNY 2.87B 259.23M 2025-06
Divis Laboratories Ltd INR 32.36B 910M 2025-03
Gilead Sciences USD 1.91B 140M 2026-03
Glaxosmithkline GBP 6.16B 39M 2026-03
Kangmei Pharma CNY 2.38B 73.9M 2026-03
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Merck USD 6.48B 179M 2026-03
Novartis USD 6.29B 135M 2026-03
Organigram Holdings CAD 135.16M 2.45M 2026-03
Organon & Co USD 1.37B 33M 2026-03
Pharma Mar EUR 53.12M 2.48M 2026-03
Qiagen NV USD 309.61M 7.72M 2026-03
Sartorius EUR 831.9M 4.8M 2026-06
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Tilray USD 282.79M 11.9M 2025-06
Zealand Pharma A/S 10.7M 9.9M 2024-12